Announced
Financials
Tags
United Kingdom
Acquisition
Pharmaceuticals
pharmaceutical company
Cross Border
Minority
Friendly
Public
Single Bidder
Pending
Mandatory Offer
Synopsis
AOP Health International Management, a European pioneer in integrated therapies for rare diseases and in critical care, agreed to acquire the remaining shares in Shield Therapeutics, a patient-focused, commercial-stage pharmaceutical company, for £33.5m. AOP and Shield have entered into the Relationship Agreement pursuant to which AOP has agreed amongst other things to permit Shield to continue to be able to operate independently of AOP.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.